葛兰素史克(US)吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 10-04 00:03
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 10-03 23:46
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 10-03 23:39
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 10-03 23:29
2 0 资讯 两大巨头女掌舵人相继宣布卸任 跨国企业面临新一轮调 默沙东资讯 09-30 23:20
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-30 00:00
2 0 资讯 葛兰素史克任命Luke Miels为候任首席执行官 葛兰素史克(US)资讯 09-29 14:21
2 0 资讯 特朗普100%药品关税引争议 白宫:不适用于已与美达成 诺华制药资讯 09-27 10:11
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-22 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-20 13:22
4 0 资讯 从GSK到奥利佳:21年老将跳槽 跨国药企迎转型阵痛 葛兰素史克(UK)资讯 09-20 13:21
4 0 资讯 葛兰素史克中国首位本土总经理齐欣离任 葛兰素史克(US)资讯 09-19 20:32
3 0 资讯 GSK大中华区副总裁齐欣离任 葛兰素史克(US)资讯 09-19 12:39
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-19 00:00
4 0 资讯 9月18日国际晨讯 | 美联储如期降息25个基点 马斯克称G 苹果资讯 09-18 08:35
5 0 资讯 关税威胁下药企在美投资承诺激增,专家:药企生产回流 葛兰素史克(US)资讯 09-17 16:13
4 0 资讯 葛兰素史克“妥协”了:在特朗普药品关税威胁下 将在 葛兰素史克(US)资讯 09-17 12:26
5 0 资讯 葛兰素史克:未来五年将在美国投资300亿美元 用于研发 葛兰素史克(US)资讯 09-17 08:07
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-17 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-17 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-16 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-15 00:00
5 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-05 00:00
5 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-04 00:00
5 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-04 00:00
2 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-03 00:00
2 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-02 00:00
3 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-02 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-02 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-28 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-27 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-26 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-22 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-21 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-21 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-20 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-19 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-19 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-18 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-15 00:00
3 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-14 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-13 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-12 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-12 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-11 00:00
3 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-11 00:00
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-08 00:00
3 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-08 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-07 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-06 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-05 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-04 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-01 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-01 00:00
4 0 资讯 葛兰素史克二季度总营收80亿英镑,同比增长6% 葛兰素史克(UK)资讯 07-31 19:45
5 0 资讯 葛兰素史克二季度总营收80亿英镑,同比增长6% 葛兰素史克(US)资讯 07-31 19:35
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-31 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-30 00:00
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-30 00:00
6 0 资讯 恒瑞医药与GSK达成授权交易:总金额最高120亿美元 恒瑞医药资讯 07-29 03:01
1 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-29 00:00
6 0 资讯 4千亿巨头涨停!恒瑞医药回应125亿美元GSK合作细节 恒瑞医药资讯 07-28 15:51
7 0 资讯 恒瑞医药与GSK达成授权合作,首付款5亿美元 恒瑞医药资讯 07-28 14:06
4 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-28 00:00
3 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-28 00:00
5 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-25 00:00
6 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-24 00:00
5 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-24 00:00
6 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-23 00:00
5 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-23 00:00
4 0 资讯 葛兰素史克公司:FDA已接受其呼吸道合胞病毒疫苗扩大 葛兰素史克(US)资讯 07-14 14:50
8 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-11 18:32
8 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-10 18:23
7 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-09 18:22
8 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-08 18:31
8 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-07 23:16
8 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-07 19:38
9 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-07 18:12
8 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-03 18:05
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
温馨提示: 1.根据《证券法》规定,禁止编造、传播虚假信息或者误导性信息,扰乱证券市场;2.用户在本社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-61278686 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:4000300059/952500